BamSEC and AlphaSense Join Forces
Learn More

Elutia Inc. – Credit Agreements

NASDAQ: ELUT    
Share price (11/4/26): $0.76    
Market cap (11/4/26): $33.6 million

Credit Agreements Filter

EX-10.48
from 10-Q 14 pages Supplement to the Loan and Security Agreement Dated as of August 11, 2026 Among Elutia Inc., a Delaware Corporation, (“Parent”), Elutia Med LLC, a Delaware Limited Liability Company (“Elutia Med”; and Together With Parent, Jointly and Severally, Individually and Collectively, “Borrower”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership (As Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership (“Avenue 2”) as a Lender and Avenue Growth Lending Fund III, L.P., a Delaware Limited Partnership (“Avenue 3”) as a Lender
12/34/56
EX-10.47
from 10-Q 34 pages Loan and Security Agreement Dated as of August 11, 2026 Among Elutia Inc., a Delaware Corporation (“Parent”), and Elutia Med LLC, a Delaware Limited Liability Company (“Elutia Med”; and Together With Parent, Jointly and Severally, Individually and Collectively, “Borrower”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership (As Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership, (“Avenue 2”) as a Lender and Avenue Growth Lending Fund III, L.P., a Delaware Limited Partnership (“Avenue 3”) as a Lender
12/34/56
EX-10.1
from 8-K 160 pages Fifth Amendment to Credit Agreement
12/34/56
EX-10.38
from 10-Q 95 pages Fourth Amendment to Credit Agreement
12/34/56
EX-10.1
from 8-K 95 pages Third Amendment to Credit Agreement
12/34/56
EX-10.1
from 8-K 78 pages Credit Agreement Among Aziyo Biologics, Inc., as Borrower, Swk Funding LLC, as Agent, Sole Lead Arranger and Sole Bookrunner, and the Financial Institutions Party Hereto From Time to Time as Lenders Dated as of August 10, 2022
12/34/56
EX-10.4
from 10-K 11 pages Amendment No. 2 to Amended and Restated Credit and Security Agreement
12/34/56
EX-10.3
from 10-K 10 pages Amendment No. 2 to Amended and Restated Credit and Security Agreement
12/34/56
EX-10.14
from S-1/A 144 pages Amendment No. 1 to Amended and Restated Credit and Security Agreement
12/34/56
EX-10.13
from S-1/A 139 pages Amendment No. 1 to Amended and Restated Credit and Security Agreement
12/34/56
EX-10.11
from S-1 137 pages Amended and Restated Credit and Security Agreement (Revolving Loan) Dated as of July 15, 2019 by and Among Aziyo Biologics, Inc., Aziyo Med, LLC and Any Additional Borrower That Hereafter Becomes Party Hereto, Each as Borrower, and Collectively as Borrowers, and Midcap Funding IV Trust, as Agent and as a Lender, and the Additional Lenders From Time to Time Party Hereto
12/34/56
EX-10.10
from S-1 131 pages Amended and Restated Credit and Security Agreement (Term Loan) Dated as of July 15, 2019 by and Among Aziyo Biologics, Inc., Aziyo Med, LLC and Any Additional Borrower That Hereafter Becomes Party Hereto, Each as Borrower, and Collectively as Borrowers, and Midcap Financial Trust, as Agent and as a Lender, and the Additional Lenders From Time to Time Party Hereto
12/34/56